← Leaderboards
Weiwen Long
Wright State University
$2,132,593
Attributed
$2,132,593
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $450K · FY2015–24$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,132,593 · 2
By mechanism
R01$1,682,593 · 1
R15$450,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsGrowthMutationOverexpressionTumor GrowthIn VitroMediatingMouse ModelNeoplasm MetastasisOncogenicSignal TransductionTumorTumor ProgressionResponseCancer Cell GrowthGene ExpressionDrug TargetingMolecularCell MotilityIn VivoCancer CellCoculture TechniquesKnockout MiceLung
Grant awards (6)
FBXL16 as a novel factor in promoting endocrine therapy resistance and metastasis of ER+ breast cancer$450,000
R15 · FY2024 · CA · contact PI
ERK3 Kinase Signaling in Lung Cancer$328,393
R01 · FY2019 · CA · contact PI
ERK3 Kinase Signaling in Lung Cancer$338,550
R01 · FY2018 · CA · contact PI
ERK3 Kinase Signaling in Lung Cancer$338,550
R01 · FY2017 · CA · contact PI
ERK3 Kinase Signaling in Lung Cancer$338,550
R01 · FY2016 · CA · contact PI
ERK3 Kinase Signaling in Lung Cancer$338,550
R01 · FY2015 · CA · contact PI